Jan 12 (Reuters) – Eli Lilly said on Monday it is confident about the supplies of its weight-loss pill orforglipron ahead of its anticipated U.S. approval in the coming months.
“We intend to launch in many, many countries around the world, as quickly as possible,” Daniel Skovronsky, Lilly head of research and development, told Reuters in an interview on the sidelines of a major industry conference that kicked off Monday in San Francisco.
(Reporting by Maggie Fick and Michael Erman in San Fransisco; Writing by Mariam Sunny in Bengaluru; Editing by Maju Samuel)
Brought to you by www.srnnews.com
